Learn / COAG
NASDAQ: COAG
Hemab Therapeutics Holdings (COAG) stock, explained like you're 5
Hemab Therapeutics Holdings trades on the Nasdaq under the ticker COAG. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
- Ticker
- COAG
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 1.5 billion dollars
Is Hemab Therapeutics Holdings a small, medium or large cap company?
No. Hemab Therapeutics Holdings is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.5 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Hemab Therapeutics Holdings makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves COAG stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Hemab Therapeutics (COAG) Stock Forecast and Price Target 2026 (MarketBeat)
- Hemab Therapeutics Holdings (COAG) Joins Russell Indices, Is The Stock Still Trading At A Discount? (Yahoo Finance)
- symbol__ Stock Quote Price and Forecast (CNN)
- COAG Initiated Coverage by JP Morgan Rating Overweight, Targe (GuruFocus)
- Hemab Therapeutics (NASDAQ:COAG) Stock Price Up 8.4% Here's What Happened (MarketBeat)
Follow COAG in your daily brief
Each trading day at 5 PM ET we post what happened to Hemab Therapeutics Holdings and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow COAG
Questions about Hemab Therapeutics Holdings stock
What does Hemab Therapeutics Holdings do?
Hemab Therapeutics Holdings trades on the Nasdaq under the ticker COAG. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 1.5 billion dollars.
What is the ticker symbol for Hemab Therapeutics Holdings?
Hemab Therapeutics Holdings trades under the ticker COAG on the Nasdaq.
What is Hemab Therapeutics Holdings's market cap?
Hemab Therapeutics Holdings is a small cap stock with a market cap of about 1.5 billion dollars.
How does Hemab Therapeutics Holdings make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves COAG stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow COAG stock every day?
Add COAG to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.